ALS (motor neurone disease) trials in Japan
2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleFirst in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
- Where
- Kyoto, Ōta-ku, Sapporo, Tokushima
- Age
- 18 years and over
- People
- 54 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06351592 · EU 2023-510344-20-00 - No phaseTaking peopleLung Insufflation Capacity Training and Respiratory Function in Amyotrophic Lateral Sclerosis
- Where
- Kodaira
- Age
- 20 years and over
- People
- 25
- Run by
- National Center of Neurology and Psychiatry, Japan
See details and how to joinNCT07257302